HR HER2- Breast Cancer
Showing 9976 - 10000 of >10,000
Breast Carcinoma Trial in Copenhagen (Partial breast irradiation, Whole breast irradiation)
Active, not recruiting
- Breast Carcinoma
- Partial breast irradiation
- Whole breast irradiation
-
Copenhagen, Copenhagen Ø, DenmarkThe Danish Breast Cancer Cooperative Group
Feb 24, 2020
Recurrent/Metastatic Breast Cancer Trial in Changchun (TQB3616 Capsule)
Completed
- Recurrent/Metastatic Breast Cancer
- TQB3616 Capsule
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 18, 2022
Necrotizing Fasciitis, Fournier Gangrene, Necrotizing Soft Tissue Infection Trial in Créteil (non interventional)
Recruiting
- Necrotizing Fasciitis
- +2 more
- non interventional
-
Créteil, FranceHopital Henri Mondor
Nov 22, 2021
Urinary Bladder Cancer Trial in Tucson (Gemcitabine)
Not yet recruiting
- Urinary Bladder Cancer
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 21, 2022
Stratification for pT4bN0M0 Colorectal Cancer Following
Completed
- Colorectal Cancer
- multivisceral resection
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Oct 30, 2023
Heart Failure, Cardiotoxicity, Cancer Trial (Cardio-oncology Rehabilitation (CORE), PAI Group (PAI), Exercise Guidelines for
Not yet recruiting
- Heart Failure
- +2 more
- Cardio-oncology Rehabilitation (CORE)
- +2 more
- (no location specified)
Aug 19, 2021
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Cancer
- Nab paclitaxel
- +2 more
- (no location specified)
Dec 5, 2022
Chronic Pain, Cancer Pain Trial in New York (MORE treatments, Standard of Care for Pain Management)
Recruiting
- Chronic Pain
- Cancer Pain
- MORE treatments
- Standard of Care for Pain Management
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
May 17, 2023
ArtiSential in Colorectal Cancer Surgery Using Prospectively
Recruiting
- Rectal Cancer
- +2 more
- ArtiSential
-
Seoul, Korea, Republic ofSamsung Medical Center
Oct 4, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +3 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
Lymphoma Trial (Fatigue Reduction Diet, General Health Curriculum)
Not yet recruiting
- Lymphoma
- Fatigue Reduction Diet
- General Health Curriculum
- (no location specified)
Sep 14, 2023
Insomnia, Insomnia Due to Medical Condition, Cancer Trial in Boston (STEP-YA with Coaching, STEP-YA without Coaching)
Recruiting
- Insomnia
- +2 more
- STEP-YA with Coaching
- STEP-YA without Coaching
-
Boston, MassachusettsDana-Farber Cancer Institute
Dec 12, 2022
sCD8, as a Novel Biomarker for Pancreatic Cancer
Recruiting
- Serum Biomarker
- Pancreatic Cancer
- serum test
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 11, 2022
Breast Cancer, Breast Tumors Trial in Uden (Adherence Improving self-Management Strategy, Regular care)
Recruiting
- Breast Cancer
- Breast Neoplasms
- Adherence Improving self-Management Strategy
- Regular care
-
Uden, NetherlandsBernhoven
Jan 18, 2021
Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab
Not yet recruiting
- Colorectal Cancer
- +3 more
- Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023
Cancer Trial in Indianapolis, Pittsburgh, Memphis (MAAT-YS)
Not yet recruiting
- Cancer
- MAAT-YS
-
Indianapolis, Indiana
- +2 more
Nov 27, 2023
Advanced Lung Cancer Trial in Hangzhou (WTX212A injection)
Not yet recruiting
- Advanced Lung Cancer
- WTX212A injection
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Oct 27, 2023
Tumors Trial in Strasbourg (Advance Care Planning Intervention)
Not yet recruiting
- Neoplasms
- Advance Care Planning Intervention
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Nov 20, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +21 more
- Atezolizumab
- +8 more
-
Little Rock, Arkansas
- +97 more
Jan 27, 2023
Colorectal Cancer, Liver Metastases Trial (QBECO, Placebo)
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- QBECO
- Placebo
- (no location specified)
Jan 6, 2023